Live Price
Live Volume
Insmed Market Segments
Overnight
*No Trades in Segment
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
| Open | $94.96 |
|---|---|
| Close | $94.88 |
| Low | $94.88 |
| Low Change | -0.08 (-0.08%) |
| High | $95.35 |
| High Change | +0.39 (+0.41%) |
| Range | $0.47 |
| Volume | 455.583K |
| Dollar Volume | $43.23M |
Regular Trading Hours Yesterday
| Open | $93.33 |
|---|---|
| Close | $95.00 |
| Low | $92.87 |
| Low Change | -0.46 (-0.49%) |
| High | $96.37 |
| High Change | +3.04 (+3.26%) |
| Range | $3.50 |
| Volume | 2.858M |
| Dollar Volume | $271.48M |
Premarket Yesterday
| Open | $93.51 |
|---|---|
| Close | $94.20 |
| Low | $93.51 |
| Low Change | 0.00 (0.00%) |
| High | $94.86 |
| High Change | +1.35 (+1.44%) |
| Range | $1.35 |
| Volume | 3.795K |
| Dollar Volume | $357.49K |
Insmed News
3 weeks agoinvesting.comWhy is Insmed stock sliding today?
- 3 weeks agoinvesting.com
Insmed stock falls as CFO Sara Bonstein to step down
- 1 month agoinvesting.com
Why is Insmed stock climbing today?
- 1 month agoinvesting.com
Insmed stock rises on FDA priority review for Arikayce
- 6 months agoinvesting.com
Why is Insmed stock sliding today?
- 7 months agoinvesting.com
Insmed stock falls after failed hidradenitis suppurativa trial
- 7 months agoinvesting.com
Insmed stock gains on UTHR trial read-through, Morgan Stanley upgrade
- 7 months agoinvesting.com
Insmed shares rise as Arikayce trial data point to larger market opportunity
- 10 months agoinvesting.com
Insmed stock rises after strong BRINSUPRI launch, ARIKAYCE revenue beat
10 months agobenzinga.comNike, Insmed, And Arm Are Among Top 10 Large Cap Losers Last Week (Dec. 15-Dec. 19): Are the Others in Your Portfolio?
Insmed Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Insmed Moving Averages
| 5 Day Moving Average (SMA5) | $94.19 |
|---|---|
| 10 Day Moving Average (SMA10) | $95.53 |
| 20 Day Moving Average (SMA20) | $99.82 |
| 50 Day Moving Average (SMA50) | $113.94 |
| 100 Day Moving Average (SMA100) | $111.06 |
| 200 Day Moving Average (SMA200) | $126.28 |
Insmed Statistics
| Average Volume (30 Days) | 2.52M |
|---|---|
| P/E Ratio (Current) | -25.09 |
| EPS (Current) | -$4.01 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$807.67M |
| Cash Ratio | 1.24 |
| Current Ratio | 3.72 |
| Quick Ratio | 3.40 |
| Debt to Equity | 0.75 |
| Enterprise Value | $21.99B |
| EV to EBITDA | -26.79 |
| EV to Sales | 19.33 |
| Price to Book | 29.00 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 19.31 |
| Return on Assets | -0.42% |
| Return on Equity | -1.16% |
Insmed Stock Splits
There has been 1 stock split for Insmed (INSM). The reverse stock split occured on March 3, 2011 and reduced the outstanding shares at a ratio of 10:1.
| Date | Type | Ratio |
|---|---|---|
| Mar 3, 2011 | Reverse | 10:1 |
Insmed Dividends
There have been no dividends for Insmed (INSM).